Asia Pacific Cell & Gene Therapy Third-party Logistics Market Size & Outlook
Related Markets
Asia Pacific cell & gene therapy third-party logistics market highlights
- The Asia Pacific cell & gene therapy third-party logistics market generated a revenue of USD 2,050.5 million in 2024.
- The market is expected to grow at a CAGR of 12.5% from 2025 to 2030.
- In terms of segment, clinical was the largest revenue generating type in 2024.
- Commercial is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, China is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 2,050.5 million |
| Market revenue in 2030 | USD 4,118.2 million |
| Growth rate | 12.5% (CAGR from 2025 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Commercial |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Clinical, Commercial |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 19.1% of the global cell & gene therapy third-party logistics market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 4,118.2 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell & Gene Therapy Third-Party Logistics Market Scope
Cell & Gene Therapy Third-Party Logistics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Knipper | View profile | 11-50 | Saarbrücken, Saarland, Germany, Europe | https://knipper.de |
| Arvato | View profile | 10001+ | Arras, Nord-Pas-de-Calais, France, Europe | https://arvato.fr/ |
| Kuehne and Nagel | View profile | - | - | - |
| United Parcel Service of America, Inc. | View profile | - | - | - |
| McKesson Corporation | View profile | - | - | - |
| EVERSANA | View profile | 5001-10000 | Milwaukee, Wisconsin, United States, North America | https://www.eversana.com |
| Cencora Inc | View profile | 46000 | 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 | https://www.cencora.com |
| FedEx Corp | View profile | 787400 | 942 South Shady Grove Road, Memphis, TN, United States, 38120 | https://www.fedex.com |
| DHL Group | View profile | 594396 | Platz der Deutschen Post, Bonn, NW, Germany, 53250 | http://www.dpdhl.com |
| Cardinal Health Inc | View profile | 48000 | 7000 Cardinal Place, Dublin, OH, United States, 43017 | https://www.cardinalhealth.com |
Asia Pacific cell & gene therapy third-party logistics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell & gene therapy third-party logistics market will help companies and investors design strategic landscapes.
Clinical was the largest segment with a revenue share of 92.85% in 2024. Horizon Databook has segmented the Asia Pacific cell & gene therapy third-party logistics market based on clinical, commercial covering the revenue growth of each sub-segment from 2018 to 2030.
The Asia Pacific cell & gene therapy third-party logistics market is projected to grow at the highest CAGR over the forecast period. The growth of the market is due to rising pharmaceutical manufacturing, vaccine exports, and increasing demand for biologics. The region is witnessing immense investments in temperature-controlled warehouses, IoT-based tracking systems, and express cold-chain transportation.
Reasons to subscribe to Asia Pacific cell & gene therapy third-party logistics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific cell & gene therapy third-party logistics market databook
-
Our clientele includes a mix of cell & gene therapy third-party logistics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific cell & gene therapy third-party logistics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific cell & gene therapy third-party logistics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific cell & gene therapy third-party logistics market size, by country, 2018-2030 (US$M)
Asia Pacific Cell & Gene Therapy Third-Party Logistics Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
